• OPEN AN ACCOUNT
Indian Indices
Sensex
78,205.98 639.82
( 0.82%)
Global Indices
Nasdaq
47,737.88 215.33
(0.45%)
Dow Jones
6,814.47 53.45
(0.79%)
Hang Seng
54,146.56 1,417.84
(2.69%)
Nikkei 225
10,395.67 146.15
(1.43%)
Forex
USD-INR
91.85 0.10
(0.11%)
EUR-INR
106.60 0.13
(0.12%)
GBP-INR
123.04 0.62
(0.51%)
JPY-INR
0.58 0.00
(-0.25%)

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532331
INE031B01049
330.3875196
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AJANTPHARM
38.87
36652.99
EPS(TTM)
Face Value()
Div & Yield %
75.48
2
0.96
 

V-Mart Retail rallies after revenue jumps 10% YoY in Q3 FY26.
Jan 05,2026
The quarter witnessed a shift in sales owing to a larger share of Durga Puja festivities falling in Q2 in the current year, compared with the previous year.

Same-store sales growth (SSSG) remained flat during the quarter, with V-Mart reporting nil growth, while Unlimited, the fashion retail chain acquired from Arvind Fashions in 2021, recorded a 2% increase.

During the quarter, the company opened 23 and closed 2 stores. This brings year-to-date (YTD) additions to 63 and closures to 6, resulting in a total operating portfolio of 554 stores as at Q3 end.

The 23 new stores include 5 stores in Uttar Pradesh, 4 stores in Gujarat, 3 stores Bihar, 2 stores each in Haryana, Madhya Pradesh & Tamil Nadu, and 1 store each in Delhi, Chhattisgarh, Uttarakhand, Jharkhand and Punjab.

V-Mart operates a chain of value retail stores across multiple Indian cities. The company reported standalone net loss of Rs 8.87 crore in Q2 FY26 compared with net loss of Rs 56.51 crore in Q2 FY25. Net sales surged 22.1% YoY to Rs 806.87 crore in Q2 FY26.